Carmustine
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Carmustine is a generic chemotherapy drug used to treat certain cancers, such as brain tumors and Hodgkin's lymphoma. Manufactured by Dr. Reddy's Laboratories Inc., it comes as a 100 mg vial for intravenous injection. This prescription medication is approved under ANDA213207 and marketed as a kit starting October 2025. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Carmustine
Access the FDA dataset for Carmustine — ANDA 213207 submitted by Mylan Institutional LLC
Modified Mar 23, 2026